Rare case of Myasthenia Gravis with Thymoma at Fortis, Vashi ft Dr Prriya Eshpuniyani

Published On 2023-07-19 09:21 GMT   |   Update On 2023-07-19 09:49 GMT
Advertisement

Akash Ingale, was admitted to Fortis Hospital, Vashi, diagnosed with the unusual combination of Myasthenia Gravis and Thymoma. Myasthenia Gravis is a chronic autoimmune neuromuscular disease causing muscle weakness, typically affecting older individuals, making it rare in young patients like Akash. Moreover, the presence of Thymoma in conjunction with Myasthenia Gravis is even rarer, occurring in only 10-12% of cases. For the past eight months, Akash faced significant mobility challenges, severely impacting his quality of life. Managing the conditions required him to be on multiple drug regimens, including steroids and immunosuppressants, further affecting his well-being.

In this video, Dr Prriya Eshpuniyani, Consultant- Thoracic OncoSurgeon Fortis Hospital, Vashi, Navi Mumbai talks about case history, challenges, prognosis.


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News